Curis Lifesciences Ltd. Company History and Annual Growth Details

Our Company was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 (“Partnership Act”) in the name and style of “M/s Loreto Pharmaceutacals”, pursuant to a deed of partnership dated June 2, 2010. Thereafter " M/s Loreto Pharmaceuticals” was converted from Partnership Firm to a Private Limited Company under the Companies Act, 2013 in the name of “Curis Lifesciences Private Limited” and received a certificate of incorporation datedMarch 23, 2016 issued by Assistant Registrar of Companies, Gujarat. Subsequently, our Company was converted into a public limited company and the name of our Company was changed from “Curis Lifesciences Private Limited” to “Curis Lifesciences Limited” vide Special Resolution dated May 6, 2024, the status of the Company was changed to public limited and the fresh certificate of incorporation consequent to conversion, bearing Corporate Identification Number U24230GJ2016PLC086559, was issued on August 9, 2024 by the Assistant Registrar of Companies/ Deputy Registrar of Companies/ Registrar of Companies, Central Processing Centre. From year 2010 to 2016, our partnership firm was engaged in the marketing and trading of various pharmaceutical products. As a partnership firm, our product portfolio included tablets, capsules, oral liquids, creams, ointments, injections, lotions, oral powders and other nutraceuticals products. We procured finished goods from manufacturers and distributed them to various wholesalers and other clients throught the country.

MAJOR EVENTS:

2011

- Started Business by starting a Partnership Firm with two Partners in name of "M/s Loreto Pharmaceutical" by Mr. Dasharathbhai Patel and Mr. Piyush Gordhanbhai Antala.

2016

- The Partnership Firm got converted into Private Company post conversion and receiving Certificate of Incorporation on March 23rd, 2016.

2018

- The Company received FDA License for manufacturing Pharma products.

2019

- The Company availed Kenya PPC board approval and approval from Ministry of Health - Republic of Yemen, State Good Manufacturing Practices and GLP licence from Local FDA 

2020

- The Company received WHO GMP certificate.

2021

- The Company received FDA Approval from Philippines during the tragic era of COVID-19

2022

- Renewal of the WHO Certificates and Nigeria NAFDAC Approval

2023

- Retention of FDA License for manufacturing Pharma products.

2025

- Conversion From Private Limited into Public Limited company.